Why the study?
Relatively few studies had detailed the real-world effectiveness and safety of accelerated diagnostic protocols using high sensitivity cardiac troponin.
Does the implementation of the ESC 0/3-hour accelerated diagnostic protocol using high sensitivity troponin T improve early ED discharge rates without compromising safety in patients with suspected acute coronary syndrome?
Does the implementation of the ESC 0/3-hour accelerated diagnostic protocol using high sensitivity troponin T improve early ED discharge rates without compromising safety in patients with suspected acute coronary syndrome?
Implementation of the ESC 0/3-hour accelerated diagnostic protocol using high-sensitivity troponin T safely doubles the rate of early emergency department discharge for patients with suspected acute coronary syndrome.
May support higher ED discharge in suspected ACS without MACE signal; leaves open randomized confirmation before practice change.
Background There have been relatively few studies detailing the real-world effectiveness and safety of accelerated diagnostic protocols (ADP), using high sensitivity cardiac troponin (hs-cTn). Objective To analyse the safety and effectiveness of early emergency department (ED) discharge following implementation of the European Society of Cardiology (ESC) 0/3-hour ADP for suspected acute coronary syndromes (ACS). Method We prospectively studied 2 cohorts of consecutive suspected ACS presentations to ED before (n=1642) and after (n=1376, 2 centres) implementation of the ESC 0/3-hour ADP incorporating limit of detection rule out. Safety was defined by MACE (major adverse cardiac events) inclusive of type 1 myocardial infarction (MI) in patients discharged from ED, and clinical effectiveness by percentage ED discharge. Continuous variables and categorical data were evaluated by independent t-test and χ 2 test, respectively. Time-to-event data were analysed as survival data and converted to Kaplan-Meier curves for interpretation. Results In the preimplementation period, there was a higher prevalence of MI. Discharge from ED increased by >100% (from 27.1% to 56.5% of the cohort) with no safety signal (MACE rate 4/444 (0.9%) vs 4/769 (0.52%), p=0.430 for the 2011 and 2018 cohort, respectively). This correlated with a marked reduction in length of stay overall but a more modest reduction for those discharged from ED (6 hours 10 min vs 5 hours 25 min, p<0.001) for the 2011 and 2018 cohort, respectively. There were improvements in presentation to blood draw (163–90 min, p<0.001). Time from presentation to first ECG actually increased (16.2 vs 31.2 min, p<0.001). Analysis of hs-cTn values and ECGs revealed a maximum ED discharge rate of 69%, by applying the 0/3-hour protocol, implying potential for increasing safe ED discharge. Conclusions Implementation of an ADP with hs-cTn is safe and effective for early rule-out and discharge of suspected ACS but require considerable resources and education to optimise maximal patient flow.
No takes yet. Share an insight, caveat, or question.
Hatherley et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: